<DOC>
	<DOCNO>NCT01492166</DOCNO>
	<brief_summary>This study conduct Asia . The aim study ass efficacy , safety convenience use Mixtard速 30 NovoLet速 use alone combined oral hypoglycaemic agent ( OHA ) management type 2 diabetes mellitus out-patient setting .</brief_summary>
	<brief_title>Observational Study Efficacy , Safety Convenience Using Mixtard速 30 NovoLet速 Alone Combined With OHA Treatment Type 2 Diabetes Routine Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin , pork ; isophane insulin , pork drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 2 diabetes Not adequately control current therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>